Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
about
Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells.A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth.Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesMolecularly targeted therapies in non-small-cell lung cancer annual update 2014Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancerTherapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer.Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics.The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma.MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung CancerPhase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.A critical question for cancer therapy: what new targets exist?Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma.Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils.Systems medicine approaches for peptide array-based protein kinase profiling: progress and prospects.Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma.
P2860
Q33722285-940D69CD-F5D4-450B-AD2F-944E92A5F8E5Q33877489-A52483C6-506C-4423-99B5-18CB4A4A9F17Q34158454-74494BF2-DB1A-45AC-9A24-856D330483C2Q35136424-BD20E359-8E6E-45C0-9D25-3194A606F6B7Q36562072-A72F7A95-6E68-4238-87E5-6DDD22953C6CQ36824455-D0FC95CC-050F-4733-A1E5-CEAD0D032525Q36958365-32190ECE-1FF0-4338-9BE0-F6F74851D9BBQ37117628-ECA84135-96CC-4C35-99A4-699B8720FDECQ37538547-D00AE8C2-435B-4C47-B834-1A5BB0F8713DQ37564619-703300A1-C665-4B22-8599-9F454948126FQ38296670-27C21EDB-8364-4A64-8EFD-4EDC576EC534Q38543678-35E9D7B8-AA7C-4BA4-ADDD-0FDFAD2FB53BQ38694303-A9B919DC-39A5-4AB4-99DC-73A001809FCAQ38718726-F353E719-1073-4D3C-B7A2-732AECA24486Q38760569-D0A60F89-B7A6-42AF-A1D7-42ED9B6AA6A1Q38864169-C1BC5635-D187-4E46-A77E-29B3BB731048Q38978586-8898C281-1BEB-409F-81A4-38579F6F60D7Q38986202-CDC0289F-A613-496F-8D1E-2A9579BDE0C6Q41940514-25A48F66-A18A-4665-B4CF-8DED4C927C89Q44718464-8B5F1864-E0E8-4E18-A72D-D01C305B6957Q49790269-B7A7D1BA-1487-4141-9194-0222D4994C56Q51729425-44E18027-0D00-453F-89D0-BCB4FF6C3E0BQ55032209-1CE931FD-A8FF-4560-A61F-EB58AC84385B
P2860
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dramatic antitumor effects of ...... in non-small cell lung cancer.
@en
Dramatic antitumor effects of ...... in non-small cell lung cancer.
@nl
type
label
Dramatic antitumor effects of ...... in non-small cell lung cancer.
@en
Dramatic antitumor effects of ...... in non-small cell lung cancer.
@nl
prefLabel
Dramatic antitumor effects of ...... in non-small cell lung cancer.
@en
Dramatic antitumor effects of ...... in non-small cell lung cancer.
@nl
P2093
P2860
P1433
P1476
Dramatic antitumor effects of ...... in non-small cell lung cancer.
@en
P2093
Aliya N Husain
Erin Smithberger
Ichiro Kawada
Jeffrey Mueller
Qudsia Arif
Rifat Hasina
P2860
P304
P356
10.1158/0008-5472.CAN-12-3583
P407
P577
2013-12-04T00:00:00Z